These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Use of omeprazole during pregnancy--no hazard demonstrated in 955 infants exposed during pregnancy. Källén BA. Eur J Obstet Gynecol Reprod Biol; 2001 May 15; 96(1):63-8. PubMed ID: 11311763 [Abstract] [Full Text] [Related]
7. Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations. Wikner BN, Stiller CO, Bergman U, Asker C, Källén B. Pharmacoepidemiol Drug Saf; 2007 Nov 15; 16(11):1203-10. PubMed ID: 17894421 [Abstract] [Full Text] [Related]
11. Peptic ulcer disease with related drug treatment in pregnant women and congenital abnormalities in their offspring. Bánhidy F, Dakhlaoui A, Puhó EH, Czeizel AE. Congenit Anom (Kyoto); 2011 Mar 15; 51(1):26-33. PubMed ID: 20727001 [Abstract] [Full Text] [Related]
13. Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study. Nørgaard M, Pedersen L, Gislum M, Erichsen R, Søgaard KK, Schønheyder HC, Sørensen HT. J Antimicrob Chemother; 2008 Jul 15; 62(1):172-6. PubMed ID: 18400803 [Abstract] [Full Text] [Related]
14. Maternal use of loperamide in early pregnancy and delivery outcome. Källén B, Nilsson E, Otterblad Olausson P. Acta Paediatr; 2008 May 15; 97(5):541-5. PubMed ID: 18394096 [Abstract] [Full Text] [Related]
17. Use of herbal drugs during early pregnancy in relation to maternal characteristics and pregnancy outcome. Holst L, Nordeng H, Haavik S. Pharmacoepidemiol Drug Saf; 2008 Feb 15; 17(2):151-9. PubMed ID: 17992658 [Abstract] [Full Text] [Related]
18. Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes. Ruigómez A, García Rodríguez LA, Cattaruzzi C, Troncon MG, Agostinis L, Wallander MA, Johansson S. Am J Epidemiol; 1999 Sep 01; 150(5):476-81. PubMed ID: 10472947 [Abstract] [Full Text] [Related]
19. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors. Lazzaroni M, Bianchi Porro G. Ital J Gastroenterol Hepatol; 1999 Sep 01; 31 Suppl 1():S73-8. PubMed ID: 10379473 [Abstract] [Full Text] [Related]
20. Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity. Schaefer C. Birth Defects Res A Clin Mol Teratol; 2003 Aug 01; 67(8):591-4. PubMed ID: 14632309 [Abstract] [Full Text] [Related] Page: [Next] [New Search]